tiprankstipranks
Spectral Medical (TSE:EDT)
TSX:EDT

Spectral Medical (EDT) Stock Statistics & Valuation Metrics

20 Followers

Total Valuation

Spectral Medical has a market cap or net worth of C$404.92M. The enterprise value is C$420.76M.
Market CapC$404.92M
Enterprise ValueC$420.76M

Share Statistics

Spectral Medical has 292,562,930 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding292,562,930
Owned by Insiders
Owned by Institutions

Financial Efficiency

Spectral Medical’s return on equity (ROE) is 0.68 and return on invested capital (ROIC) is 26.80%.
Return on Equity (ROE)0.68
Return on Assets (ROA)-7.82
Return on Invested Capital (ROIC)26.80%
Return on Capital Employed (ROCE)0.19
Revenue Per Employee84.21K
Profits Per Employee0.00
Employee Count29
Asset Turnover0.40
Inventory Turnover20.15

Valuation Ratios

The current PE Ratio of Spectral Medical is ―. Spectral Medical’s PEG ratio is -0.04.
PE Ratio
PS Ratio169.36
PB Ratio-5.93
Price to Fair Value-5.93
Price to FCF-42.55
Price to Operating Cash Flow-39.61
PEG Ratio-0.04

Income Statement

In the last 12 months, Spectral Medical had revenue of 2.44M and earned -47.69M in profits. Earnings per share was -0.17.
Revenue2.44M
Gross Profit-5.16M
Operating Income-11.69M
Pretax Income-47.69M
Net Income-47.69M
EBITDA-11.44M
Earnings Per Share (EPS)-0.17

Cash Flow

In the last 12 months, operating cash flow was -10.16M and capital expenditures -28.00K, giving a free cash flow of -10.19M billion.
Operating Cash Flow-10.16M
Free Cash Flow-10.19M
Free Cash Flow per Share-0.03

Dividends & Yields

Spectral Medical pays an annual dividend of C$0.12, resulting in a dividend yield of ―
Dividend Per ShareC$0.12
Dividend Yield
Payout Ratio
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.85
52-Week Price Change91.67%
50-Day Moving Average1.34
200-Day Moving Average1.29
Relative Strength Index (RSI)51.23
Average Volume (3m)78.93K

Important Dates

Spectral Medical upcoming earnings date is May 8, 2026, TBA (Confirmed).
Last Earnings DateMar 26, 2026
Next Earnings DateMay 8, 2026
Ex-Dividend Date

Financial Position

Spectral Medical as a current ratio of 0.08, with Debt / Equity ratio of -30.25%
Current Ratio0.08
Quick Ratio0.07
Debt to Market Cap0.05
Net Debt to EBITDA-1.49
Interest Coverage Ratio-2.26

Taxes

In the past 12 months, Spectral Medical has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

Spectral Medical EV to EBITDA ratio is -37.66, with an EV/FCF ratio of -44.30.
EV to Sales176.33
EV to EBITDA-37.66
EV to Free Cash Flow-44.30
EV to Operating Cash Flow-45.21

Balance Sheet

Spectral Medical has C$4.07M in cash and marketable securities with C$21.09M in debt, giving a net cash position of -C$17.02M billion.
Cash & Marketable SecuritiesC$4.07M
Total DebtC$21.09M
Net Cash-C$17.02M
Net Cash Per Share-C$0.06
Tangible Book Value Per Share-C$0.24

Margins

Gross margin is 12.29%, with operating margin of -478.50%, and net profit margin of -1952.99%.
Gross Margin12.29%
Operating Margin-478.50%
Pretax Margin-1952.87%
Net Profit Margin-1952.99%
EBITDA Margin-468.26%
EBIT Margin-478.50%

Analyst Forecast

The average price target for Spectral Medical is C$3.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetC$3.50
Price Target Upside153.96% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast34.85%
EPS Growth Forecast-62.50%

Scores

Smart ScoreN/A
AI Score